Kuros Biosciences AG appointed Daniel Geiger as Chief Financial Officer (CFO) as of May 1, 2023, who is transitioning from his current role as CFO-ad interim. Daniel Geiger quickly adapted to Kuros' culture and is a proven leader to develop and execute Kuros' pivotal growth strategy.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.86 CHF | -0.44% | -8.53% | +96.56% |
Apr. 24 | Kuros Biosciences Posts Higher Q1 Product Sales | MT |
Apr. 17 | Kuros Biosciences AG Approves Board of Director and Committee Changes | CI |
1st Jan change | Capi. | |
---|---|---|
+96.56% | 276M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- KURN Stock
- News Kuros Biosciences AG
- Kuros Biosciences AG Appoints Daniel Geiger as Chief Financial Officer